Oxford Biomedical......the way forward !!!

BBG British Bio tipped as a share of the year in the Mail today Saturday.
I only say this here as, OXB has many similarities ie very good cash position..

but OXB is the better company in future product terms I believe. We have EVERY cahnce of getting somewhere in the next year or so.
Look at Alizyme for example.. good stage 2 and 3 products, but cash will run out late 2003... what then?
If BBG is a buy for 03 so is OXB- 2003 is a year of the Biotechs.
OXB and BBG can put fingers up to bad dealmakers as they are not in hawk.
Apart from fags sector, nearly every other sector is 'spavined' ( f'*ucked to you). .
We could have a very good year ahead. In fact, I'm damn sure we will.